『The Dime』のカバーアート

The Dime

The Dime

著者: Bryan Fields
無料で聴く

Most cannabis companies won't survive the next three years. The ones that do will have better capital discipline, sharper regulatory reads, and operational frameworks built for compression, not growth. The Dime is where cannabis operators, executives, and investors hear directly from the CEOs and founders making those decisions right now: MSO strategy, state-by-state market dynamics, cultivation and extraction economics, brand positioning, and the financing structures keeping companies alive. Bryan Fields hosts weekly conversations built for operators, not observers.© 2026 The Dime マネジメント マネジメント・リーダーシップ リーダーシップ 化学 科学 経済学
エピソード
  • Paige Figi: The Cannabis Industry Is Cheering A Ban On Medicine
    2026/08/04
    Much of the licensed cannabis industry is quietly counting the volume it expects to inherit from the federal hemp ban coming this November. ** Now December. What they may not realize is that the ban could eliminate the full-spectrum therapeutic hemp formulations that helped change America's view of cannabis and are used daily by an estimated 45 million Americans. The provision was written by two members of Congress, without a conference or regular order, and inserted into a massive spending bill during the longest government shutdown in American history. What should have been handled with a scalpel was done with a sledgehammer. This week we sit down with Paige Figi to discuss • Silence is a position • The scalpel Congress skipped • Oval Office, then banned Chapters 00:00 Introduction to the legislative landscape of cannabis 00:21 The impact of Charlotte's story on cannabis perception 00:48 Distinguishing hemp from marijuana in legislation 02:11 The challenges of passing therapeutic hemp laws 02:52 Congress's need for simple, effective regulation 03:48 The slow progress of therapeutic hemp legalization 04:53 The importance of clear plant distinctions 05:56 The November 12 hemp ban and its implications 07:02 The dangers of Franken hemp and synthetic cannabinoids 08:00 The public health emergency posed by recent bans 08:49 The role of science and data in regulation 10:13 The importance of industry and public unity 10:58 How regulations can support medical and adult use 12:06 The impact of federal bans on patients and consumers 13:00 The need for a balanced, science-based approach 14:00 The political landscape and legislative hurdles 14:53 The power of public advocacy and individual action 16:07 The future of cannabis regulation and industry alignment 17:06 How to effectively communicate with policymakers 18:03 The importance of clear, science-backed legislation 19:00 The role of the FDA and federal agencies 20:01 The potential for bipartisan support and progress 21:08 The significance of the November 12 deadline 22:06 The ongoing fight for access and regulation 23:04 The moral and ethical considerations in cannabis policy 23:49 How consumers can influence policy change 24:47 The importance of unity within the industry 25:46 The potential for a balanced, effective regulatory framework 27:06 The role of science and data in shaping policy 28:03 The need for responsible, clear regulations 29:02 The future outlook for therapeutic hemp and CBD 30:02 Final thoughts and call to action Guest Links https://www.coalitionforaccess.org/ https://www.instagram.com/paigefigi/ https://realmofcaring.org/about/paige-figi/ Our Links Bryan Fields on Twitter The Dime on Twitter Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. The Dime is a top 5% most shared global podcast The Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished. 🎥 YouTube: The Dime 📸 Instagram: The Dime https://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
    続きを読む 一部表示
    53 分
  • Understand This Before You Use AI To Build Software ft. Chris Guthrie
    2026/07/09

    AI has made software easier than ever to build. That does not mean every internal tool should become the backbone of your business.

    In this episode, Bryan sits down with Chris Guthrie to break down the growing temptation inside cannabis companies to vibe code internal tools, dashboards, CRMs, ERPs, and operational systems in the name of saving money.

    The problem is not the first version. The problem is what happens two months later, when a field does not map, the workflow breaks, the person who built it is unavailable, and a production team is now relying on code nobody fully understands.

    Chris explains the difference between a useful AI-built prototype and an enterprise-grade system that can survive real operators, messy data, security needs, compliance, multiple departments, M&A diligence, and future FDA-style requirements.

    This conversation covers why descriptive data does not create predictive insight, why Google Sheets to vibe coding can become a path to failure, and why the real AI opportunity starts after the business has clean data, clean processes, and a system strong enough to trust.

    This episode covers:

    • The weekend build that fails
    • Descriptive data will not predict
    • Clean books before M&A

    Chapters

    00:00 The Rise of AI in Software Development

    03:07 Challenges of Internal Software Development

    06:09 Understanding What 'Works' in Software

    09:10 The Risks of Vibe Coding

    12:05 The Importance of Established Infrastructure

    14:58 Cost Considerations in Software Development

    17:56 Predictive Insights and Data Utilization

    21:13 Defining Core Business Focus

    23:17 The Challenges of AI Implementation

    27:00 Understanding AI's Limitations

    28:58 The Importance of Data Governance

    31:11 Navigating Change Management in Cannabis

    35:51 Preparing for Industry Evolution

    40:09 The ROI of ERP Systems

    Our Links:

    Bryan Fields on Twitter

    The Dime on Twitter

    Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

    At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

    The Dime is a top 5% most shared global podcast

    The Dime is a top 10 Cannabis Podcast

    The Dime has a New Website. Shhhh its not finished.

    🎥 YouTube: The Dime

    📸 Instagram: The Dime

    https://www.newton-insights.com/


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    続きを読む 一部表示
    50 分
  • Hirsh Jain: Rescheduling Is Already Picking Winners
    2026/06/25

    Cannabis rescheduling is not as simple as “Trump rescheduled cannabis.”

    States are interpreting rescheduling completely differently depending on their license structure. These tiny details are widening the gap between potential winners and losers.

    In this episode, we break down what actually changed, what is still unresolved, and why rescheduling may already be picking winners and losers.

    This week, we sit down with Hirsh Jain to discuss:

    • What the April order and June 29 hearing actually mean

    • How the DEA registration portal could impact operators

    • The three pathways for interstate commerce

    • Why state license structure may determine who is positioned for a national market

    Chapters

    00:00 Understanding Cannabis Rescheduling

    02:53 The Implications of Medical vs. Adult Use Cannabis

    05:48 Navigating Federal Legality for Medical Cannabis

    09:03 DEA Registration: A New Era for Cannabis Businesses

    11:53 The Complexities of DEA Registration

    15:02 Interstate Commerce: The Future of Cannabis Trade

    17:46 State Models and Their Impact on Cannabis Regulation

    21:02 Winners and Losers in the Cannabis Market

    24:04 The Role of Politics in Cannabis Regulation

    27:01 The Future of Interstate Commerce in Cannabis

    38:15 Understanding the Dormant Commerce Clause

    40:46 Interstate Commerce and Political Friction

    42:43 Legal Challenges to Cannabis Rescheduling

    44:37 The April Order and Its Implications

    51:05 Upcoming Hearings and Their Significance

    59:22 Emerging Markets in Red States

    01:05:34 Cultural Shifts and Legal Implications

    01:10:16 Looking Ahead: Signals for Progress

    Guest Links:

    https://www.anandastrategy.com/

    Our Links:

    Bryan Fields on Twitter

    The Dime on Twitter

    Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

    At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

    The Dime is a top 5% most shared global podcast

    The Dime is a top 10 Cannabis Podcast

    The Dime has a New Website. Shhhh its not finished.

    🎥 YouTube: The Dime

    📸 Instagram: The Dime

    https://www.newton-insights.com/


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    続きを読む 一部表示
    1 時間 12 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません